Q301--Kidney Disease Gene Panel 1-Year Testing Indy, Cleveland, Cincinnati VA Medical Centers
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the Richard L. Roudebush VA Medical Center in Indianapolis, IN, is conducting market research through a Sources Sought Notice to identify potential contractors for Kidney Disease Gene Panel Testing and related services. This requirement extends to the Louis Stokes Cleveland VA Medical Center and Cincinnati VA Medical Center. The government anticipates a one-time contract with a one-year base period. Responses are due by March 13, 2026, at 8:30 AM EDT.
Scope of Work
The contractor will provide reference laboratory testing services, including specialized kidney gene panel testing (analysis of over 380 genes), kidney transplant assessment (non-invasive donor-derived cell-free DNA blood test), and molecular residual disease (MRD) assay (personalized tumor-informed assay). Services encompass providing necessary supplies for specimen collection, packaging, and shipping; maintaining specimen integrity; and transmitting results via a secured web-based portal. All services must comply with applicable federal and state regulations, including CAP, CLIA, The Joint Commission, NFPA 99, OSHA, and HIPAA. The Laboratory Director must be a licensed American Board of Pathology certified pathologist.
Contract & Timeline
- Type: Sources Sought Notice (for market research)
- Intended Contract: One-time contract with a one-year base period
- NAICS Code: 621511 – Medical Laboratories (Size Standard: $41.5 Million)
- Product Service Code: Q301 – Medical Reference Laboratory Testing
- Response Due: March 13, 2026, at 8:30 AM EDT
- Published: March 11, 2026
Submission & Eligibility
Interested parties should submit responses via email to Jessica.Bryant5@va.gov with the subject line "36C25026Q0377 - Kidney Disease Gene Panel – Firm Name". Submissions must include completed sections C-G of the provided document, relevant attachments, Contractor Point of Contact information, and Company Information (Name, Address, DUNS, Tax ID, Business Size/Type). For SDVOSB/VOSB, a copy of VetCert Certification is required. Contractors should indicate if they hold a Federal Supply Schedule contract for these services or if they are offering open market. An official quote for the specified services is also requested. All prospective contractors must be registered in SAM.gov.
Additional Notes
This is solely for information and planning purposes and does not constitute a solicitation. A draft Performance Work Statement (PWS) and test list with estimated quantities are attached. Participating facilities include Richard L. Roudebush VA Medical Center (Indianapolis), Louis Stokes Cleveland VA Medical Center (Cleveland), and Cincinnati VA Medical Center (Cincinnati).